Hemovent
Manufacturing · Germany · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Rottstrasse 33, Aachen, Nordrhein-Westfa...Phone Number
+49 2419901330Website
www.hemovent.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Hemovent
Hemovent specializes in innovative ECMO technology, providing mobile and intuitive heart-lung support systems designed for high demands in clinical settings. Their flagship products, MOBYBOX and MOBYO, are engineered for emergency situations, patient stabilization, and mobility, ensuring functionality even without stable power sources. With over 25 years of MedTech expertise, Hemovent aims to make complex systems clinically intuitive and effective, enhancing patient care in various environments. The company is based in Aachen, Germany, and is committed to safety and efficacy in medical technology.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hemovent your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Hemovent
Click to see if Hemovent had a recent Job posting/layoffs
Product Launch: Get notified when Hemovent launches new products
Funding: Get notified immidiatlly once Hemovent has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Hemovent is spiking on competitors!
Earning: See what the market has to say on Hemovent recently announced quarterly report
Check if Hemovent has recently received funding, and reach out quickly before it becomes old news!
Hemovent, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hemovent is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hemovent is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hemovent.
Hemovent financials insights
Gather financial insights about Hemovent, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2017
Grant
$810K
Series A
$2M
2020
Series B
$10.7M
Hemovent Tech Stack
A closer look at the technologies used by Hemovent
Hemovent News & Media
MIG sells portfolio company Hemovent to MicroPort
MIG sells portfolio company Hemovent to MicroPort Submitted 05/10/2021 - 10:21am MIG Capital AG has sold portfolio company, Hemovent to MicroPort Surgical BV, a subsidiary of Shanghai-based MicroPort Scientific Corporation, (MicroPort) for a total purchase price of up to EUR123 million. Split between two funds MIG holds more than 27 per cent of Hemovent. Hemovent develops and manufactures Extra Corporal Lung Support (ECLS) systems for the intensive care setting. Based on the classic heart-lung mECLS-Unternehmen Hemovent von MicroPort übernommen – Investitionen zur Expansion der Präsenz in Deutschland
AACHEN und SHANGHAI--(BUSINESS WIRE)--MicroPort Scientific Corporation (nachstehend „MicroPort®“) meldete am 4. Oktober 2021, dass das Unternehmen über seine Intensivpflege-Tochtergesellschaft MicroPort Surgical B.V. („MicroPort® Surgery“) 100 Prozent des vorhandenen Eigenkapitals der Hemovent GmbH (nachstehend „Hemovent“) für insgesamt bis zu 123 Millionen Euro in bar erworben hat. Nach Abschluss der Akquisition wird Hemovent eine hundertprozentige Tochtergesellschaft von MicroPort® sein. HemoLa société Hemovent, spécialiste des systèmes extracorporels de maintien des fonctions vitales (ECLS), a été rachetée par MicroPort et s’attend à une augmentation notable de ses activités en Allemagne
AIX-LA-CHAPELLE (Allemagne) et SHANGHAI--(BUSINESS WIRE)--MicroPort Scientific Corporation (ci-après «MicroPort®») a annoncé le 4 octobre 2021 avoir racheté, par l’intermédiaire de sa filiale spécialisée en systèmes de soins intensifs MicroPort Surgical B.V. (ci-après «MicroPort® Surgery»), l’intégralité du capital de Hemovent GmbH (ci-après «Hemovent») détenu par les actionnaires, pour un montant total d’environ 123 millions d’euros en espèces. Une fois l’acquisition finalisée, Hemovent devienRiassunto: L'Azienda ECLS Hemovent è stata acquisita da MicroPort e riceve investimenti nell'espansione delle attività in Germania
ACQUISGRANA, Germania e SHANGHAI--(BUSINESS WIRE)--MicroPort Scientific Corporation (d'ora in avanti “MicroPort®”) ha annunciato il 4 ottobre 2021, tramite la sua controllata di terapia intensiva, MicroPort Surgical B.V. (“MicroPort® Surgery”), l'acquisizione del 100% dell'equità detenuta dagli azionisti esistenti di Hemovent GmbH (d'ora in avanti “Hemovent”) per un totale in contanti pari a €123 milioni. Alla conclusione della transazione, Hemovent diventerà un'azienda interamente controllata
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hemovent
Sign Up For FreeTo access detailed company insights
Hemovent specializes in innovative ECMO technology, providing mobile and intuitive heart-lung support systems designed for high demands in clinical settings. Their flagship products, MOBYBOX and MOBYO, are engineered for emergency situations, patient stabilization, and mobility, ensuring functionality even without stable power sources. With over 25... Read More
